
Jeffrey Testani
Director of Heart Failure Research, Cardiovascular Medicine · Yale School of Medicine
Credentials: · · · · ·
History
PresentHeart & Vascular Center · Yale School of Medicine
Present
Research
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
New England Journal of Medicine · 2021 · 1,462 citations
European Journal of Heart Failure · 2019 · 851 citations
Circulation · 2010 · First of 5 authors · Corresponding · 548 citations
- PW
49 papers
- ZC
Zac Cox
46 papers
- MB
27 papers
- CP
26 papers

24 papers

22 papers · 6 as a resident

22 papers

22 papers
Grants
- 2018–2031
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart Failure
National Heart, Lung, and Blood Institute · R01
Contact PI · $5M · Yale University
- 2024–2029
Exploring Water Free Sodium Storage
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.2M · Yale University
- 2022–2027
Mechanisms of Diuretic Resistance in Heart Failure
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.7M · Yale University
- 2021–2027
Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3.7M · Northern California Institute/Res/Edu
Clinical trials
- 2026–2027
Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Principal investigator · Active not recruiting · Phase 4
Yale University
- 2025–2028
- 2024–2029
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Principal investigator · Recruiting · Phase 1
Yale University
- 2023–2026
Empagliflozin in Patients With Cirrhosis and Ascites
Principal investigator · Recruiting · Phase 2
Yale University




